Use, understanding, and perceptions of gut microbiome research and practices in oncology

Courtney B Cross1,2, Maya R Davies3,4, Elin Irestorm5,6

  • 1School of Pharmacy and Biomedical Sciences, College of Health, Adelaide University, Adelaide, Australia. courtney.cross@adelaide.edu.au.

Abstract

Insights

The gut microbiome is recognized for its role in cancer treatment. However, more resources and expertise are needed to translate this understanding into clinical practice, despite widespread interest among supportive care professionals.

Area of Science:

  • Oncology
  • Microbiome Research
  • Cancer Therapeutics

Background:

  • The gut microbiome's influence on cancer treatment efficacy and toxicity is increasingly acknowledged.
  • Translating microbiome research into clinical benefits is challenging due to inconsistent methods and potential research biases.
  • Understanding current practices and perceptions is crucial for advancing microbiome-based cancer care.

Purpose of the Study:

  • To characterize the current practices and perceptions of the gut microbiome within the Multinational Association of Supportive Care in Cancer (MASCC).
  • To identify barriers and facilitators for integrating gut microbiome research and clinical applications in oncology.

Main Methods:

  • A mixed-methods survey was distributed to MASCC members in 2022.
  • The survey collected data on current research, clinical use, future plans, and perceptions of the gut microbiome in cancer care.
  • Quantitative data were analyzed using descriptive statistics, and qualitative responses underwent inductive thematic analysis.

Main Results:

  • A majority of respondents (83%) believe the gut microbiome is important in cancer.
  • 44.4% reported ongoing gut microbiome research or clinical practice, with 70.5% interested in developing such programs.
  • Qualitative analysis identified key themes including the state of evidence, perceived significance, uncertainty, aspirations, preferences, and critiques regarding microbiome research.

Conclusions:

  • There is broad agreement on the significance of the gut microbiome in cancer care.
  • Significant interest exists in leveraging the gut microbiome, but resource support (funding, infrastructure) and expertise are lacking.
  • High-quality trials are needed to generate evidence for implementing microbiome-based sampling or therapeutics in clinical practice.

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...